4//SEC Filing
Nunes Anne 4
Accession 0001171843-24-005510
CIK 0000898437other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:06 PM ET
Size
9.4 KB
Accession
0001171843-24-005510
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Exercise/Conversion
Common Stock
2024-10-01+2,491→ 14,211 total - Exercise/Conversion
Restricted Stock Unit
2024-10-01−2,491→ 0 totalExercise: $0.00→ Common Stock (2,491 underlying) - Tax Payment
Common Stock
2024-10-01$24.27/sh−732$17,766→ 13,479 total
Footnotes (5)
- [F1]Reflects the third and final vesting installment of RSUs granted on October 1, 2021.
- [F2]Includes 634 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 14, 2024.
- [F3]Reflects an aggregate of 732 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on October 1, 2024.
- [F4]Reflects the closing price of ANIK common stock on October 1, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning October 1, 2022.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001982862
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:06 PM ET
- Size
- 9.4 KB